| 1 |
35260678 | Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study. | 2022 Mar 8 |
1 |
| 2 |
30291473 | The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5. | 2019 Mar |
1 |
| 3 |
31335677 | Effects of febuxostat on renal function in patients with chronic kidney disease: A systematic review and meta-analysis. | 2019 Jul |
1 |
| 4 |
28302902 | Risk of Febuxostat-Associated Myopathy in Patients with CKD. | 2017 May 8 |
2 |
| 5 |
24152124 | Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease. | 2014 Mar |
4 |